11:53 AM EST - CanniMed Therapeutics Inc. : And Aurora Cannabis have entered into a support agreement whereby the Board of Directors and the Special Committee of the CanniMed Board have agreed to support a new offer made by Aurora for the acquisition of all of the issued and outstanding shares of CanniMed not owned by Aurora. In addition to the Board and Special Committee, the new offer, as described below, will continue to be supported by certain CanniMed shareholders representing 36% of CanniMed’s outstanding shares and by Brent Zettl, President and CEO of CanniMed. CanniMed Therapeutics Inc.
shares T.CMED are trading up $5.72 at $43.23.
